StreetInsider.com  Apr 16  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Ariad+Pharma+%28ARIA%29+Will+Report+Q1+Results+May+7th%3B+Street+Expects+Narrower+Loss/9385822.html for the full story.
DailyFinance  Apr 14  Comment 
SOUTH WINDSOR, CT -- (Marketwired) -- 04/14/14 -- Ticket Summit® , the leading conference and trade show for the live entertainment and ticketing industry, recently announced its full schedule for its upcoming conference, July...
StreetInsider.com  Apr 2  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARIAD+Pharmaceuticals+%28ARIA%29+Names+Hugh+M.+Cole+as+Business+Chief/9341704.html for the full story.
Benzinga  Mar 28  Comment 
BlackBerry (NASDAQ: BBRY) shares gained 7.62% to $9.74 in the pre-market after the company posted a narrower-than-expected fourth-quarter loss. BlackBerry sold around 3.4 million smartphones in the quarter. Ariad Pharmaceuticals (NASDAQ: ARIA)...
SeekingAlpha  Mar 24  Comment 
By Mark Romero: ARIA a Look Into The Past Ariad Pharmaceuticals, Inc (ARIA) has given many the ride of their life over the past six months. ARIA fell nearly 90% stemming back to October 2013 when Iclusig (AKA Ponatinib) was pulled from the...
StreetInsider.com  Mar 24  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/ARIAD+Pharma+%28ARIA%29+Initiates+AP26113+Phase+2+in+NSCLC/9308445.html for the full story.
TheStreet.com  Mar 19  Comment 
DELAFIELD, Wis. (Stockpickr) -- Anyone who has followed me for a long time knows that I have a keen eye for spotting biotech stocks that are setting up technically for monster moves higher. >>5 Stocks Insiders Love Right Now One of my most...
DailyFinance  Mar 10  Comment 
SOUTH WINDSOR, CT -- (Marketwired) -- 03/10/14 -- Ticket Summit® , the leading conference and trade show for the live entertainment and ticketing industry, recently opened voting for sessions to be included in the schedule for its...
SeekingAlpha  Mar 4  Comment 
ARIAD Pharmaceuticals Inc. (ARIA) Cowen and Company 34th Annual Health Care Conference Call March 04, 2014 10:40 AM ET Executives Harvey Berger - Chairman and CEO Analysts Phil Nadeau - Cowen and Company Presentation ...
StreetInsider.com  Feb 26  Comment 
UPGRADES RBC Capital upgrades LinkedIn (NYSE: LNKD) from Sector Perform to Outperform and moves its price target from $225 up to $250. Click Here for more color. Bernstein raises Range Resources (NYSE: RRC) from Market Perform to Outperform with...


Ariad Pharmaceuticals develops products that use intracellular-signal-transduction pathways to treat disease. It is developing pharmaceuticals that may treat conditions such as anemia, growth-hormone deficiency, cancer, diabetes, asthma, arthritis, and osteoporosis. All of the company's products are in the research or clinical-testing stages. Ariad has not entered any partnerships for the distribution of their product candidates, preferring to have sole control of their development.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki